Pages that link to "Q45236380"
Jump to navigation
Jump to search
The following pages link to Genotypes of TNF-alpha, VEGF, hOGG1, GSTM1, and GSTT1: useful determinants for clinical outcome of bladder cancer (Q45236380):
Displaying 50 items.
- TNFRSF1B +676 T>G polymorphism predicts survival of non-small cell lung cancer patients treated with chemoradiotherapy (Q31034347) (← links)
- Large-scale evaluation of candidate genes identifies associations between VEGF polymorphisms and bladder cancer risk (Q33275297) (← links)
- The relationship between GSTA1, GSTM1, GSTP1, and GSTT1 genetic polymorphisms and bladder cancer susceptibility: A meta-analysis (Q33595451) (← links)
- The effect of hOGG1 Ser326Cys polymorphism on cancer risk: evidence from a meta-analysis (Q34082783) (← links)
- Association of the vascular endothelial growth factor -2578C/A polymorphism with cancer risk: A meta-analysis update (Q34265586) (← links)
- Meta-analysis shows strong positive association of the TNF-α gene with tumor stage in bladder cancer (Q34417254) (← links)
- Genetic and environmental determinants of risk for cholangiocarcinoma in Thailand (Q34508893) (← links)
- Associations of VEGF-C genetic polymorphisms with urothelial cell carcinoma susceptibility differ between smokers and non-smokers in Taiwan (Q35114454) (← links)
- Translational medicine and reliability of single-nucleotide polymorphism studies: can we believe in SNP reports or not? (Q35196724) (← links)
- GSTM1 and GSTT1 polymorphisms are associated with increased bladder cancer risk: Evidence from updated meta-analysis (Q36211691) (← links)
- An association between hOGG1 Ser326Cys polymorphism and the risk of bladder cancer in non-smokers: a meta-analysis (Q36367696) (← links)
- Gene polymorphisms in bladder cancer (Q37055354) (← links)
- Association between the OGG1 Ser326Cys Polymorphism and Cancer Risk: Evidence from 152 Case-Control Studies (Q37068006) (← links)
- Molecular biomarkers in urothelial bladder cancer (Q37123497) (← links)
- Genetic epidemiology of bladder cancer: scaling up in the identification of low-penetrance genetic markers of bladder cancer risk and progression (Q37278993) (← links)
- GSTT1 Null Genotype Significantly Increases the Susceptibility to Urinary System Cancer: Evidences from 63,876 Subjects (Q37290556) (← links)
- The hOGG1 Ser326Cys gene polymorphism and susceptibility for bladder cancer: a meta-analysis (Q37344334) (← links)
- Molecular markers for detection, surveillance and prognostication of bladder cancer (Q37418122) (← links)
- Targeting angiogenesis in bladder cancer (Q37428195) (← links)
- Germline genetic markers for urinary bladder cancer risk, prognosis and treatment response (Q37797468) (← links)
- VEGF pathway polymorphisms as prognostic and pharmacogenetic factors in cancer: a 2013 update (Q38148602) (← links)
- A systematic review and meta-analysis of the association between OGG1 Ser326Cys polymorphism and cancers (Q38318529) (← links)
- Tissue hOGG1 genotype predicts bladder cancer prognosis: a novel approach using a peptide nucleic acid clamping method. (Q38478600) (← links)
- Analysis of hOGG1 genotype as a prognostic marker for muscle invasive bladder cancer: A novel approach using peptide nucleic acid-mediated, real-time PCR clamping (Q38481107) (← links)
- Human 8-oxoguanine DNA glycosylase gene polymorphism (Ser326Cys) and cancer risk: updated meta-analysis (Q41280361) (← links)
- Genetic polymorphisms of glutathione S-transferase T1 and bladder cancer risk: a meta-analysis (Q43271614) (← links)
- Vascular endothelial growth factor -634G/C and vascular endothelial growth factor -2578C/A polymorphisms and lung cancer risk: a case-control study and meta-analysis (Q43973274) (← links)
- Genetic Variations of Melatonin Receptor Type 1A are Associated with the Clinicopathologic Development of Urothelial Cell Carcinoma (Q44284930) (← links)
- Polymorphisms of glutathione S-transferase μ and θ, MDR1 and VEGF genes as risk factors of bladder cancer: a case-control study (Q45333038) (← links)
- CYP1A2, CYP2D6, GSTM1, GSTP1, and GSTT1 gene polymorphisms in patients with bladder cancer in a Turkish population (Q46438256) (← links)
- A 3' untranslated region polymorphism rs2304277 in the DNA repair pathway gene OGG1 is a novel risk modulator for urothelial bladder carcinoma. (Q48048949) (← links)
- XRCC1 399 Arg-related genotype and allele, but not XRCC1 His107Arg, XRCC1 Trp194Arg, KCNQ2, AT1R, and hOGG1 polymorphisms, are associated with higher susceptibility of endometriosis. (Q53205921) (← links)
- Bladder Cancer Working Group Report (Q53294852) (← links)
- Prognostic significance of vascular endothelial growth factor gene polymorphisms in patients with colorectal cancer. (Q54284662) (← links)
- Genetic variability of vascular endothelial growth factor and prognosis of head and neck cancer in a Brazilian population. (Q54445032) (← links)
- Influence of the VEGF-A 936C>T germinal polymorphism on tumoral VEGF expression in head and neck cancer. (Q54470228) (← links)
- Possible correlation between polymorphism in the tumor necrosis factor-beta gene and the clinicopathological features of bladder cancer in Japanese patients. (Q54589538) (← links)
- Association of Urokinase Gene 3'-UTR T/C polymorphism with bladder cancer. (Q54593285) (← links)
- Association Between 12 Polymorphisms of VEGF/Hypoxia/Angiogenesis Pathway Genes and Risk of Urogenital Carcinomas: A Meta-Analysis Based on Case-Control Studies. (Q55475464) (← links)
- Polymorphisms inNQO1and the clinical course of urinary bladder neoplasms (Q57664832) (← links)
- Association of Glutathione S-transferase gene polymorphism with bladder Cancer susceptibility (Q59127377) (← links)
- Vascular endothelial growth factor gene polymorphisms in ovarian cancer (Q61853685) (← links)
- Glutathione S-transferase theta genotypes and environmental exposures in the risk of canine transitional cell carcinoma (Q64099212) (← links)
- Association between polymorphisms in the biometabolism genes CYP1A1, GSTM1, GSTT1 and GSTP1 in bladder cancer (Q79774516) (← links)
- The investigation of GSTT1, GSTM1 and SOD polymorphism in bladder cancer patients (Q79882698) (← links)
- hOGG1 Ser326Cys polymorphism is associated with risk of bladder cancer in a Chinese population: a case-control study (Q83776503) (← links)
- Association of VEGF genetic polymorphisms with the clinical characteristics of non-Hodgkin's lymphoma (Q84337369) (← links)
- Polymorphism of vascular endothelial growth factor -2578C/A with cancer risk: evidence from 11263 subjects (Q84573149) (← links)
- Association of vascular endothelial growth factor polymorphisms with clinical outcome of renal cell carcinoma patients (Q88207082) (← links)
- Association between OGG1 S326C CC genotype and elevated relapse risk in acute myeloid leukemia (Q88601242) (← links)